Medical Physics and Biophysics

Dr. Jiang has been trained in the area of biomedical optical imaging with significant experience with both complex inverse computations and experiments in biomedical contexts. He has made pioneering contributions to diffuse optical tomography, fluorescence tomography, bioluminescence tomography, and quantitative photoacoustic tomography.

Discovering and developing fundamentally new optical-based imaging technologies for in vivo visualization of tissue at both the macroscopic and microscopic scales

As an assistant professor in the UF Department of Radiation Oncology, Dr. Mamalui Hunter’s responsibilities at the University of Florida Health Proton Therapy Institute include patient treatment planning and quality assurance of radiation therapy devices. Her experience includes postdoctoral work at the New Jersey Institute of Technology and at Washington University, St. Louis where she also completed her medical physics residency training. A published researcher, her work has appeared in peer-reviewed medical journals including International Journal of Radiation Oncology Biology Physics, Physics in Medicine and Biology and Medical Physics. She is a member of the Association of Physicists in Medicine

Medical Physics

HZ received his Ph.D. from the University of Munich in1978, followed by a postdoctoral year at the University of Houston, Texas. In 1979 he was appointed Ass. Prof. at the UIUC, where he was promoted to Assoc. Prof. in 1983 and Full Prof. of Physics in 1986. From 1989 - 2012 he was Chair for Exp. Phys. at the Ruhr-Univ. Bochum, Germany. Presently he is Guest Prof. at the Universities of Mainz and Uppsala. HZ is fellow of the APS, honorary Doctor of the KTH, Stockholm, and Adjunct Prof. of the UIUC. From 2000-2003 he was SAC member for the ESS, 2003-2005 SAC chairman of SINQ, 2007 – 2010 SAC chairman of the ILL. 2013 he became the MAINZ research awardee. 2017 HZ was elected member of the European Academy of Sciences. His teaching interest is in medical physics, his main research interests are in nanomagnetism, spintronics, x-ray and neutron scattering, and in magneto-optics.

Medical Physics

Dr Tachtsidis is a biomedical engineer, he received his PhD in medical physics and biomedical optics from UCL in 2005. In 2010 he received a Wellcome Trust career development fellowship to stay in UCL and in 2015 he was awarded a Wellcome Trust senior fellowship. Dr Tachtsidis considered an expert in near-infrared spectrscopy technology and has co-authored more than 90 publications in the field of biomedical optics. Dr Tachtsidis optical systems are currently being used at UCL Hospitals to monitor brain injury patients and birth asphyxiated infants.

Medical Physics and Biomedical Engineering

Professor Morin's research interests include all aspects of Electronic Imaging in Medicine (e.g., Computed Radiography, PACS, Networks, Workstations). Additional areas include the performance and application of Fast Computed Tomography (particularly Cardiovascular CT) and Mammography Physics.

Computed Radiography, PACS, Networks, Workstations). Additional areas include the performance and application of Fast Computed Tomography (particularly Cardiovascular CT) and Mammography Physics.

Ph.D., Dept. of Mechanics and Mathematics, Moscow State University, Moscow, Russia MS, Dept. of Naval Architecture, Polytechnic Institute, Odessa, Ukraine. Naturalized US citizen (since 1985). Goal oriented, highly motivated and creative performer with proven leadership, administrative and coaching ability, extensive project and financial management experience, team player attitude, strong analytical and planning skills, effective communications (written and verbal) and presentation skills, as well as excellent organizational, interpersonal, and negotiation capabilities. Possesses thorough and in-depth understanding of the state-of-the-art in materials, mechanical, electrical, optical, information, telecommunication, reliability and related areas of engineering, of new and emerging technologies, and a clear vision for the most promising directions in the development of applied science and engineering. Works exceptionally well in dynamic and rapidly changing environments, under pressure and in short time frames. Performs effectively across multiple organizations, companies and departments, with specialists from various disciplines and fields, and with people of different mentalities, origins, and cultural backgrounds. Good public speaker. Quick learner. Exhibits strong interest in, and possesses good knowledge of, foreign cultures, values, attitudes, and customs. Always willing to learn new things and has exceptional receptiveness to, and quick grasp of, new approaches and ideas. Has a sociable disposition and gets along well with peers, supervisors and subordinates. Bi-lingual: English and Russian. Fluent in Ukrainian.

 Applied Mathematics, Applied and Mathematical Physics, Materials Science and Engineering, Applied Mechanics  Applied Probability, Probabilistic Analyses and Probability-Based Physical Designs of Electron Devices  Probabilistic Methods in Reliability Engineering, Probabilistic Risk Assessment and Management  Analytical (Mathematical) Modeling in Applied Science and Engineering  Photonics, Fiber Optics, Mechanics of Optical Fibers  Design for Reliability (DfR) of Electronic, Opto-Electronic and Photonic Systems  Composite and “Smart” Materials and Systems  Thin Film Mechanics and Physics  Shock and Vibration Analyses and Testing  Dynamic Response of Materials and Structures to Shocks and Vibrations  Thermal Stress Analysis, Prediction and Prevention of Thermal Stress Failures  Solder Materials and Solder Joint Interconnections  Embedded Systems  Polymeric Materials in Electronics and Photonics  Photovoltaic and Thermo-Electric Modules: Physical Design for Reliability  Nanotechnologies and Nanomaterials  Stretchable (Large Area) Electronics and Photonics: Physical Design for Reliability  Lattice-Misfit Systems: Stress Analysis and Reliability Evaluations  Technical Diagnostics, Prognostics and Health Monitoring (PHM)  Automotive and Aerospace Electronics and Photonics  Vehicular (Aerospace, Maritime, etc.) Missions Success and Safety  “Human-in-the-Loop”: Human-Equipment-Environment Performance and Interaction  Avionics Psychology

2001 has completed his PhD-Biophysics at the age of 30 years from Sofia University “St. Kliment Ohridski” and at 2002 a postdoctoral followship by Japanesses Society of Promotion of Sciences-JSPS for two years at National Institute of Public health-Tokyo, Japan. He was awarded by Sofia University “St. Kliment Ohridski”fondation with the price for best young Scientis for 1997. He is asistant profesor in Medical University-Sofia, faculty of Medicine since 2001. He is a vice-president of Bulgarian Society of Biomedical Physics and Engineering-BSBPE 2012-2014. He has published more than 48 papers in peer-rewiew journals, 53 citations, hi is an author of 3 books, and 148 reports from congreses and conferences.

Medical Physics and Biophysics.

Baki Karaböce has completed his PhD in Yeditepe Univertsity in İstanbul in 2014. He is head of Medical Metrology Laboratory and Head of Medical Metrology Focus Group at National Metrology Institute of Turkey. He is member of EURAMET-The European Association of National Metrology Institutes, Task Group Health and Ultrasound subcommitte. He has published more than 30 papers in journals and has been serving as steering committe member of IEEE MeMeA-Medical Measurements and Applications Sympossium.

Metrological approach in medical measurements

Dr. Stergios Stergiopoulos received a B.Sc. (Hon.) degree from the University of Athens in 1976 and the M.Sc. & Ph.D. degrees in Physics in 1977 and 1982, respectively, from York University, Toronto, Canada. Presently he is the Acting Chief Scientist at the Defence R&D Canada (DRDC) Toronto, an Associate Professor (Status Only) at the Edward S. Rogers Sr. Department of Electrical & Computer Engineering of the University of Toronto, and the main innovator of the Defence R&D Canada (DRDC) medical diagnostic technologies and patents that have been licensed for commercialization. These innovation include a number of non-invasive 3D imaging (i.e. cardiac 3D CT, portable 3D/4D ultrasound) and vital signs monitoring (i.e., motion & noise tolerant automated blood pressure and intracranial dispersive-ultrasound) technologies. To complete their development and their commercialization process, Dr. Stergiopoulos raised approximately $21 million from private investors and Government grants. He has an extensive background in science and research. Since 1991 he is with DRDC, a Research Agency for the Canadian Department of National Defence. From 1988 to 1991, he was with the NATO SACLANT Centre in La Spezia, Italy, where he performed as Senior Scientist both theoretical and experimental research in sonar signal processing. At SACLANTCEN, he developed jointly with Dr. Sullivan from US Naval Underwater Warfare Centre (NUWC) an acoustic synthetic aperture technique that has been patented by the U.S. Navy. From 1984 to 1988 he developed an underwater fixed array surveillance system for the Hellenic Navy in Greece and there he was appointed also senior adviser to the Greek Minister of Defence. From 1982 to 1984 he worked as a research associate at York University and in collaboration with the U.S.Army Ballistic Research Lab (BRL), Aberdeen,MD, on projects related to the stability of liquid filled spin stabilized projectiles. In 1984 he was awarded a U.S. NRC Research Fellowship for BRL. He was Associate Editor for the IEEE Journal of Oceanic Engineering and for this Journal he has prepared two special issues on Acoustic Synthetic Aperture and Sonar System Technology. He has published numerous scientific articles and a Handbook (i.e. 2nd Edition, CRC-Press) in the areas of advanced signal processing for sonar and medical non-invasive system applications. His present interests are associated with the implementation of advanced processing schemes in multi-dimensional arrays of sensors for sonar and medical tomography (CT, MRI and ultrasound) systems. His research activities are supported by Canadian-DND Grants, NSERC Research & Strategic Grants, the Ontario Challenge Fund and NATO collaborative Research Grants. He has been awarded with European Commission-IST grants as technical manager of several projects that included as project partners major European corporations and Institutes (i.e., Siemens, Nucletron, Philips, Sema Group, Esaote, Atmel, Fraunhofer). These project were entitled “New Roentgen”, “MITTUG”, “ADUMS”, “MRI-MARCB”, “DUST” and Euroworkshop “Fourier”, with an average budget level of the order of Euro 1.5 million per project. Dr. Stergiopoulos is a Fellow of the Acoustical Society of America and a senior member of the IEEE. He has been a consultant to a number of companies, including Atlas Elektronik in Germany, Hellenic Arms Industry and Hellenic Aerospace Industry.

His present interests are associated with the implementation of advanced processing schemes in multi-dimensional arrays of sensors for sonar and medical tomography (CT, MRI and ultrasound) systems

Dr. Jiang has been trained in the area of biomedical optical imaging with significant experience with both complex inverse computations and experiments in biomedical contexts. He has made pioneering contributions to diffuse optical tomography, fluorescence tomography, bioluminescence tomography, and quantitative photoacoustic tomography.

Discovering and developing fundamentally new optical-based imaging technologies for in vivo visualization of tissue at both the macroscopic and microscopic scales

Kiki theodorou received her Bachelor degree in Physics in 1994, a master degree in Medical Physics in 1996 and her PhD in Medical physics in 1990.she is an Associate processor in the Medical school at the University of Thessaly, in Medical Physics and Medical Informatics.

Physics of Radiotherapy, Radio biology, Advanced MRI Techniques and Radiation Protection.

Medical Physicist at Yale-New Haven Hospital · Department of Diagnostic Radiology (Imaging Services) United States. Assistant Clinical Professor at Yale University · Department of Diagnostic Radiology and Pediatric Diagnostic Radiology United States.

Medical physics

Yekta Ulgen is director of Institute of Biomedical Enginnering.His Assistant Professor Istanbul Technical University 1978 – 1980 (2 years)Istanbul, Turkey Assistant Professor Bogazici University 1980 – 1985 (5 years)Istanbul, Turkey Dept of Electrical and Electronic Engineering Bogazici university

Research Interest in Biomedical Enginnering

Assoc. Director, Medical Physics Program Biophysics and Radiation Biology B.S., Sonoma State University, Biophysics, 1980 Ph.D., University of California at Berkeley, Biophysics, 1986 Postdoctoral Positions: University of Michigan, Biophysics Division University of Michigan Medical School, Department of Radiation Oncology University of Michigan Medical School, Department of Dermatology

Medical Physics and radiation oncology

Assistant Professor in Duke University May 2009 – Present (7 years) and Faculty in Duke University Medical Physics 2009 – Present (7 years.Postdoctoral Research Associate Duke University, Durham, NC September 2007 – April 2009 and PhD and Research Assistant Duke University August 2002 – August 2007

Imaging modality - Neutron Stimulated Emission Computed Tomography (NSECT)

Assistant Professor University of Florida Director, Clinical Radiological Physics Shands Hospital Director of Clinical Radiological Physics University of Florida-Shands Health Care

Direct dosimetry measurements in CT Protocol Optimization in CT Skin Injury prevention in IR Functional MRI and DTI.

Dr. Silvia Mittler is a physicist who was educated at the Johannes-Gutenberg University in Mainz, Germany. Her diploma thesis work was conducted in the group of Prof. Paul Leiderer in the Department of Physics at the Johannes-Gutenberg University on the topic of " The Investigation of the Phase Transition between Amorphous and Crystalline Tetracene by Raman Spectroscopy" in 1986. For her PhD she joined the group of Prof. Wolfgang Knoll at the Max-Planck Institute for Polymer Research, Mainz and graduated in 1989 with a biophysical topic: "Charge Induced Phase Separation in Black Lipid Membranes". In 1990 she became a postdoctoral fellow with Prof. George Stegeman at the Optical Sciences Center of the University of Arizona and at CREOL of the University of Central Florida. Her research interests during this period were polymeric waveguide devices for nonlinear optical application and spectroscopy.

Nanotechnology Photonics

I started my research as an Engineer in The Central Research Institute of Structural Materials "Prometey" (2005-2008) in Russia where I worked developing novel materials using laser thermo-strengthening. My PhD was at Dundee University and concerned the development of novel diode lasers for biomedical applications with broad tunability in the 1.1– 1.5 μm wavelength range. The spectral versatility of the lasers was demonstrated through novel mode-locking regimes such as dual wavelength mode-locking, wavelength bistability and broad tenability. The outcomes of my research work were published in peer-reviewed high impact journals including Journal of Selected Topics in Quantum Electronics, Optics Express, and Applied Physics Letters. Furthermore, the results were disseminated at conferences such as CLEO, CLEO-Europe, and Laser Optics to ensure that academic and industrial beneficiaries were aware of my work. After my PhD I worked in The Aston Institute of Photonics Technologies and at Swansea University characterizing fibres lasers and amplifiers, performing dispersion measurement of Yb-doped fibres with white-light interferometry. For the last three years, I have been working at the University College London with a photoacoustic ultrasound system for ex-vivo and in-vivo imaging of the tissues and organs. Part of this project involved designing and making specialist holders and connectors and I chose to do this using 3D CAD software and 3D printing. I was fascinated by 3D printing technology and its possibilities, for example I used 3D printing to develop Agar-based ultrasound phantoms for vascular access training and flow studies. I also investigated properties of acoustic lenses made by 3D printing along with a colleague. Recently I joined a GIFT-SURG project as a research associate building a system that performs human placental dual perfusion (i.e. joint fetal and maternal sides) experiments. It will provide a unique platform for vascular and haematological studies such as vessel cannulation skill analysis and evaluation of novel methods for measuring blood oxygenation and flow.

I was fascinated by 3D printing technology and its possibilities

Assoc. Director, Medical Physics Program Biophysics and Radiation Biology B.S., Sonoma State University, Biophysics, 1980 Ph.D., University of California at Berkeley, Biophysics, 1986 Postdoctoral Positions: University of Michigan, Biophysics Division University of Michigan Medical School, Department of Radiation Oncology University of Michigan Medical School, Department of Dermatology

Medical Physics and radiation oncology

Maria Elisabete C.D. Real Oliveira, Associated Professor with Habilitation at Physics Department of UMinho, completed her BsC in Physics, UCoimbra, Portugal, 1975, and her PhD at the University of Salford, UK/University of Minho, in 1986. She was Head of the Master Degree in Biophysics and Bionanosystems, (2009-2014), Head of the Research Group Atomic Molecular and Optics Physics (FAMO), Centre of Physics, UM (2013-present) and President of the Group of Colloids and Polymer (Portuguese Chemical Society), since 2013. She is author of more than 54 Full Publications (ISI) in repute journals (h index-16) and author of 2 Patents. She was also Founder of the Spin-off NANODELIVERY–I&D in Bionanotecnology, LDA..

Medical physics

Dr. Rosu joined the Department of Radiation Oncology in 2007. She received her Ph.D. in Nuclear Engineering and Radiological Sciences from the University of Michigan in 2005. Following graduation Dr. Rosu was a postdoctoral fellow in the Radiation Oncology Department at the University of Michigan and her research represented one of the first comprehensive studies of the influence of motion in three-dimensional and four-dimensional treatment planning in deformable organs using Monte Carlo dose computation engine. Her current research interests include further investigations of the motion effects on dose calculation, treatment delivery and clinical outcomes.

Radiation Oncology Medical Physics

Dr Tachtsidis is a biomedical engineer, he received his PhD in medical physics and biomedical optics from UCL in 2005. In 2010 he received a Wellcome Trust career development fellowship to stay in UCL and in 2015 he was awarded a Wellcome Trust senior fellowship. Dr Tachtsidis considered an expert in near-infrared spectrscopy technology and has co-authored more than 90 publications in the field of biomedical optics. Dr Tachtsidis optical systems are currently being used at UCL Hospitals to monitor brain injury patients and birth asphyxiated infants.

Medical Physics and Biomedical Engineering

Carmel's research interests involve the understanding of the risks of very low doses of ionizing radiation to humans and the environment, with particular emphasis on the mechanisms of low-dose effects. Identification of early events and the mechanisms involved in radiation carcinogenesis are also examined. Study of the mechanisms involved in genomic instability, and their relevance to the repair of radiation damage and radiation-induced carcinogenesis. Development of bio-indicators of radiation stress in non-human species after low doses of alpha, beta, and gamma radioisotopes involve in uranium, radium, and tritium decay.

Chairman
McMaster University
Canada

Annika Lohstroh grew up in central Germany, where she studied for her undergraduate Diploma in Physics at Göttingen University. She developed an interest in nuclear solid state physics during a 6 month exchange programme with the Catholic University Louvain (Belgium). Subsequently, she continued to study this area of physics that uses techniques originating in nuclear physics to investigate semiconductor properties, like hyperfine interaction methods and ion beam analysis. She moved to Guildford during Summer 2002 and obtained her PhD at the University of Surrey, researching charge transport properties in wide band gap semiconductors for radiation detection applications, with a particular emphasis on chemical vapour deposited diamond. She extended these studies as a Research Fellow at the University of Surrey during the following years and was appointed as Lecturer in 2008. Her scientific aim is to understand the limitations of current radiation detector performance and to find ways to overcome these limits. Dr Lohstroh is currently (2010-2013) the Chair of the Radiation Detection Instrumentation Research Theme of SEPnet (South East Physics Network).

the effect of bulk and surface defects on sensor performance. the effect of electrode materials and processing for semiconductor detectors development of pulse shape analysis for research and applications

Marek Krzysztof Janiak, MD, PhD., Head of Dept. of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology in Warsaw, Poland. 1978 PhD, 1987 assist. prof., 1987 full professor in medical sci. 2007-2013 president of the Polish Radiation Research Society, member of the European Radiation Research Society, European Society for Cancer Research, Polish Immunological Society; advisor to Polish Representative to UNSCEAR. Co-author of 110 publications in radiobiology, immunology, radiation hygiene, and epidemiology. co-editor and co-author of books (in Polish): “Medicine of Radiation Hazards” (2005), “Pathology of Injuries and Diseases Caused by a War and Acts of Terrorism” (2010).

Head
Military Institute of Hygiene and Epidemiology
Poland

Professor
The University of Oklahoma
United States

Professor
University of Bath
United kingdom

Ke Li has completed his Ph.D in 2013 from the Department of Medical Physics, University of Wisconsin-Madison. He is now an Assistant Professor of the Department of Medical Physics and Department of Radiology, University of Wisconsin-Madison, working primarily in the area of x-ray mammographic imaging and CT imaging. He is the author or co-author of more than 30 scientific publications.

Hairong Zheng is a Professor of Shenzhen Institutes of Advanced Technology (SIAT),Chinese Academy of Sciences.He received his B.S. degree from Harbin Institute of Technology in 2000 and Ph.D. degree in Mechanical Engineering, Biomedical Engineering Division from University of Colorado at Boulder in 2006. He joined the University of California Davis first as a postdoctoral fellow, and then as project scientist in the Biomedical Engineering Department, before his joining SIAT by the end of 2007. Dr.Zheng is the director of SIAT-Institute of Biomedical and Health Engineering (IBHE), and director of Paul C. Lauterbur Research Centre for Biomedical Imaging. Dr.Zheng’s research areas focus on ultrasonics, ultrasonic imaging-drug delivery-therapy, and multimodality medical imaging. Dr. Zheng has published more than 100 peer-reviewed journal papers and international conference proceedings, and owned more than 20 patents. Dr. Zheng was a recipient of the Tan Kah Kee Young Scientist Award of China (2014), and National Outstanding Young Scientist Award of China(2013), American Heart Association Pre-doctoral Fellowship (2005).He is principle investigator of China 973 Project. Dr. Zheng is an Associate editor of IEEE Transactions on UFFC, editoral board member of Ultrasound in Medicine and Biology, editorial board member of Physics in Medicine and biology, the chairman of IEEE EMBS Shenzhen Chapter.

Michael Retsky (Ph.D in physics from University of Chicago) made a career change from physics to cancer research. He is Editor-in-Chief of Journal of Bioavailability and Bioequivalence, on staff at Harvard School of Public Health, honorary faculty at University College London, and Prof Adj at UANL, Monterrey, Mexico. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. He is on the board of directors of the Colon Cancer Alliance and has published more than 60 papers in physics and cancer. He has a patent pending for treatment of early stage cancer

cancer research, charged particle optics, early detection of cancer and delayed detection of cancer

Dr. Chen is an Associate Professor at the Beckman Research Institute, City of Hope. Dr. Chen received his Ph.D. in Molecular Biology at the University of Alabama at Birmingham in 1999, and completed his postdoctoral training in Cancer Biology at Johns Hopkins University in 2005. Dr. Chen’s research covers epigenetic mechanisms of tumorigenesis, gene regulation by DNA methylation and histone modifications, animal models of cancer, and stem cells. Dr. Chen’s current research is on functions of sirtuin deacetylases in aging and cancer drug resistance, in particular, in the area involving hematopoietic stem cells and leukemia stem cells

Epigenetics, Cancer, Aging and Stem Cells

Dr. Sell is a board certified pathologist and immunologist. He has published over 400 papers and 12 books. His paper with Barry Pierce (Lab. Invest. 70:6-21, 1994.) was selected as an AACR scientific landmark. Among his findings are: development of delayed hypersensitivity before antibody formation (1959). the role of the thymus in development of immune competence (1964); first identification of immunoglobulin on the surface of B cells (1965; Current contents citation classic, 1984); classification of immunopathological reactions (1971); development of a radioimmunoassay for alphafetoprotein (1972); identification of liver stem cells during chemical hepatocarcinogenesis and in response to injury (1972-94); role of endocytosis in activation of B cells (1974); recognition that the chancre of syphilis is a delayed hypersensitivity reaction (1979); role of mGSTA3 in detoxification of aflatoxin (2004); and characterization of breast cancer stem cells (2012)

Cancer: To determine how bone marrow derived mesenchymal stem cells influence the development of cancers in other tissues. Cancer: To block proliferation of breast cancer stem cells by small molecular inhibitors or inhibitory RNA. This is a critical step to preventing re-growth of breast cancer after chemotherapy or radiation therapy. Carcinogenesis: To study the metabolism of aflatoxin and development of liver cancer in mice lacking glutathionine-S-transferase. Aging: To compare the ability of young vs. old bone marrow derived stem cells to reconstitute and provide long term survival after lethal irradiation and transplantation, and the ability of wild-type bone marrow to prolong life of early aging mice.

Bradford has a PhD in Medical Biochemistry- Oncology from the Roswell Park Cancer Institute, Division of SUNY at Buffalo School of Medical and Biomedical Sciences. She is the inventor of the various patents that AccuTheranostics holds. She was awarded the Award for Excellence in Research from the American Federation for Clinical Research, has authored many scientific papers and book chapters, and been an invited speaker at various international scientific meetings. Dr. Bradford is a member of many major professional cancer organizations including, ASCO, AACR and AAAS. As Chief Scientific Officer, Dr. Bradford guides the day-to-day research directives as well as the clinical laboratory operations.

President, CSO and Founder
AccuTheranostics, Inc.,USA

Bishayee is the Chair and Associate Professor of Pharmaceutical Sciences, American University of Health Sciences, Signal Hill, CA. Dr. Bishayee’s research focuses on elucidation of the cancer preventive and therapeutic effects of medicinal plants, natural products, dietary and synthetic agents using various pre-clinical models of cancer. The ongoing projects of Dr. Bishayee are funded by the National Institutes of Health as well as private pharmaceutical/biotechnological institutions. Dr. Bishayee has published more than 86 original research papers and review articles in high-impact, peer-reviewed journals, 9 book chapters, and presented over 25 papers at various national and international scientific meetings.

Assistant Dean and Chair
Associate Professor of Pharmaceutical Sciences
American University of Health Sciences
Signal Hill, USA

Professor Shiaw-Yih Lin has studied DNA damage response in cancer for 10+ years, during which time he has authored more than 40 peer-reviewed reports. He has served on the editorial boards for the World Journal of Clinical Oncology, American Journal of Cancer Research, Frontiers in Molecular and Cellular Oncology, World Journal of Translational Medicine, and Experimental Hematology & Oncology. Dr. Lin is a member of the International Scientific Advisory Board for International Institute of Anticancer Research, and he has served on numerous review committees for the NIH, DOD and Susan G. Komenfor the Cure.

DNA damage checkpoint and DNA repair
Genetic and chemical screens
Cancer stem cells
Cancer gene signatures

Dr. Lu’s work is to delineate the mechanisms of cellular signaling regulation in cancer cell metabolism, proliferation, migration and metastasis. His laboratory focuses on three areas: understanding how cancer advances by altering cancer cell metabolism; understanding how cancer cells migrate, invade and metastasize, and understanding how cancer progresses by promoting cell survival. He is an associate editor of Chinese Journal of Cancer and an editorial board member of other 8 journals including Cell Research and Neuro-Oncology

Tumor cell invasion and metastasis, cancer cell metabolism

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013-); Visiting Professor in Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX, USA (2012–2013); Visiting Professor in Department of Pathobiology, College of Veterinary Medicine, The University of Missouri-Columbia, MO, USA (2012); Visiting Professor in Department of Foods and Nutrition, The University of Georgia, GA, USA (2011 – 2012); Visiting Professor in Division of Endocrinology and Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, GA, USA (2007 – 2011); Professor in Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1993 ~ August 2007); Associate Professor in Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1991~1993); Assistant Professor in School of Pharmaceutical Sciences, University of Shizuoka, Japan (1987~1991); Visiting Assistant Professor in The University of Texas Medical School at Huston, USA (1988); Assistant Professor in Shizuoka College of Pharmacy, Japan (1986~1987); Visiting Assistant Professor in Texas Tech University School of Medicine, USA (1985); Visiting Lecturer in The University of Pennsylvania School of Medicine, USA (1981); Research Associate in Shizuoka College of Pharmacy, Japan (1973 ~ 1986). He received a Ph.D. in Pharmaceutical Sciences from Shizuoka College of Pharmacy (1976, Japan). He has completed his B.S. in Pharmaceutical Sciences, Shizuoka, Japan (1971).Dr. Yamaguchi is serving as editors and editorial board members of reputed 24 international Journals. He received many honor and awards.

cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetic osteoporosis, and cancer bone metastasis and osteolysis.

Dr. Salem Chouaib completed his undergraduate studies at the university of Pierre and Marie Curie (Paris VI) at Pasteur Institute. He received his Doctorat es-sciences (Ph.D.) in immunology, (laboratory of Jean Dausset, Nobel prize in medicine) in 1983 from the same university. He then joined the Memorial Sloan Kettering Cancer Center in New York where he undertook a post-doctoral training in Human Immnogenetics Laboratory. In 1986, he was appointed as research associate at the French National Institute of Health and Biomedical Research (INSERM) and joined the tumor biology department at the Institut Gustave Roussy. At present he is research director and is heading the INSERM research unit 753 (Human Cancer Immunology and Immunotherapy). Dr Chouaib’s laboratory currently focuses on the investigation of the functional cross talk between cytotoxic cells and tumor targets in the context of tumor microenvironment complexity and plasticity. Dr Chouaib research was constantly directed at impulsing the transfer of fundamental concepts in clinical application in particular in the field of cancer vaccine and cancer immunotherapy. He was awarded the cancer research prize of the French ligue against cancer in 1992 and in 2004 the presidential prize in biotechnology. He is lecturing tumor immunology for the PhD programs at the University Paris Sud. His research resulted in more than 220 scientific articles and several reviews in the field of human immunology and tumor biology as well as in editorship for contribution to several books. Furthermore he is guest lecturer at different universities. He is ad hoc referee for numerous journals and scientific foundations. He is a member of various professional associations and is scientific advisor and consultant in many scientific institutions.

Cell-mediated cytotoxicity, tumor microenvironment, immunology and immunotherapy of cancer.

Dr. Siddiqui earned his BSc and MSc degrees in Biochemistry from the University of Karachi, in Karachi, Pakistan. He obtained his PhD from the Australian National University in Canberra, Australia. While obtaining his PhD, he investigated the metabolic basis of cancer cachexia under the supervision of Professor John F. Williams, who is famous for his pioneer research on the pentose phosphate pathway. Dr. Siddiqui served as a postdoctoral fellow at Massey University in Palmerton North, New Zealand in the laboratory of Dr. Stuart McCutcheon (currently Vice Chancellor of Auckland University in New Zealand). Dr. Siddiqui immigrated to America in 1989 and worked as a Howard Hughes fellowship at Vanderbilt University Medical Center in Nashville with Dr. John Exton. Dr. Siddiqui began his work as a researcher at Methodist Hospital in 1993 in the Bone Marrow Transplant Research Laboratory. He established his independent research laboratory in 1999 and is presently the Senior Investigator and Director of the Cellular Biochemistry Research Laboratory at the Methodist Research Institute. Dr. Siddiqui also has adjunct appointments in the Department of Biology, Indiana University-Purdue University and the Department of Medicine, Indiana University Medical School, Indianapolis. Dr. Siddiqui has received funding from the National Cancer Center (NIH), American Heart Association, Showalter Foundation, Abbott Pharmaceuticals, and Baxter Nutrition.

Dr. Siddiqui´s research interests are in the area of cancer, inflammation, and cardiovascular diseases. His research emphasis is on the synergistic modulation of breast cancer progression by combination of nutrients and drugs with omega-3 fatty acids.

Professor Ivan Gout graduated as an MD at Lviv Medical University (Ukraine) in 1983. He obtained his doctorate at the Institute of Experimental Oncology, National Academy of Sciences of Ukraine in 1987. In 1998, he started his own group at the Ludwig Institute for Cancer Research, focussing on the regulation of growth via the S6 kinase pathway. Since 2003, he has been a Professor in this Department, where he has an active research group working on signal transduction via the mTOR/S6K pathway in normal and cancer cells.

Cell signalling through phospholipases, kinases and G-proteins during differentiation and secretion, Cellular mechanisms underlying neurodegeneration.

Samir A. Farghaly is Physician / Scientist and national and international expert in Obstetrics and Gynecology – faculty member at the Medical College of Cornell University, and the New York Presbyterian Hospital/ Cornell University Medical Center, New York, NY – USA. He received his M.D degree from University College, London University and his PhD degree in molecular biology from London University. He was affiliated with Columbia University College of Physicians and surgeons/ Columbia University medical center, New York, NY. He received several national and international clinical and research awards. He has been an invited speaker in several national and international conferences on Women’s health, Molecular genetic of female cancers, Gynecological cancer and Oncology. He is a member of several national and international societies, organizations, foundations of Women health and Cancer. He is an editor, member of editorial boards, editorial advisory boards and reviewers of several medical journals of Cancer Science & Therapy, Gynecology, Gynecological Cancer, Genomics, Clinical & Experimental Obstetrics and Gynecology, and Oncology. He has published 78 articles in reputed peer review journals. He has written several books chapters, and is an editor of (2) books in Obstetrics and Gynecology, published in Feb. 2012, and the third book to be published in June 2013.

Obstetrics and Gynecology
Cornell University
USA

Unique blend of academic excellence and entrepreneurship, heading leading firms in India- Teleradiology Providers, company that provides teleradiology services in India and DAMS (Delhi Academy of Medical Sciences) Premier test preparation institute in India for MD/MS/MCI/USMLE preparation. To his credit is DAMS, unique country wide class room programme with many first\'s in the industry -like Tablet based learning called as iDAMS and use of web 2.0 technologies in medical education and radiology. He has also been an invited faculty member at various conferences, including Teleradiology in IRIA 2008 & 2011, Hospital Build Middle East, and Congress of the Brain Tumor Radiology in Neuro-oncology Society. He has been visiting international faculty member of Tripoli Universities, Libya. In 2012, IRIA he was invited to speak on Entrepreneurship in Radiology. He is on consulting panel with various agencies including GLG council.
Dr. Sethi is Editor-in-Chief of Internet Journal of Radiology.

He has a keen interest in Web 2.0 technologies and in maintaining his famous radiology blog, which has been featured in multiple international journals.

Gustavo G. Volpi is Argentinean, has advanced studies in Bioengineering, Faculty of Engineering, UNER (Universidad Nacional de Entre Ríos) and 12 years of experience in Computed Tomography (Axial, Helical, and Multislice) and Nuclear Magnetic Resonance. Leading his company, DICOM IT, in Argentina, he has made training and specific training sessions in the United States about Installations and Maintenance (Corrective and Preventive) applied to equipment manufactured by Philips (MX8000 and Brilliance, GyroScan Intera). He currently makes Installations and Corrective and Preventive Maintenance throughout Latin America.

Computed Tomography, Magnetic Resonance Imaging

Dr. Du received his bachelor degree in technological physics from Beijing University in 1995 and master degree in solid state physics from Institute of Physics, Chinese Academy of Sciences in 1998. His PhD is in medical physics from the University of Wisconsin-Madison. Dr. Du joined the UCSD faculty as an Assistant Professor of Radiology in 2005 and an Associate Professor since 2010. Dr. Du’s research interests are in the field of magnetic resonance imaging, focusing on ultrashort TE (UTE) imaging of short T2 tissues such as cortical bone, tendons, menisci, ligaments, calcified cartilage and calcification in soft tissues. Dr. Du has authored more than 70 peer-reviewed articles with a focus on osteoporosis, osteoarthritis and angiography. Dr. Du’s awards include the RSNA Research Scholar (2008) and the American Heart Young Investigator Award (2008). Dr. Du received funding support from NIH, GE HealthCare, Department of Veterans Affairs, Bracco Diagnostic Inc. and UCSD Academic Senate. Biography

Dr. Du research interests are in the area of Magnetic Resonance Imaging, especially in the field of musculoskeletal MRI and MR angiography. Research Interest

Yu kuang did his works 8/2004 to 3/2009 Case Western Reserve University, Cleveland, OH, 44106, Ph.D. in Biomedical Engineering, Dissertation: PET Imaging of Hepatocellular Carcinoma with Radiolabled Choline, 9/2001 to 6/2004 Zhejiang University, Hangzhou, 310027, P. R. China, Master of Science in Biomedical Engineering (3-year program), Thesis: Image Reconstruction of Cardiovascular Cross Sections from Biplane Orthogonal Projections of X-Ray Angiography, 9/1992 to 6/1997 Zhejiang University, Hangzhou, 310027, P. R. China. Bachelor of Engineering in Biomedical Engineering (5-year program).

His research interest includes Radiation Physics, Molecular Imaging, Nuclear Medicine Radiation Oncology

Dr. Miyamoto currently holds four academic appointments at Temple University as Chief in Medical Oncology, including Acting Service Chief in Medical Oncology, Medical Director at the Cancer Center, Professor and Chairperson of the Hospital, and Professor in Radiation Oncology. He is a staff radiation oncologist at the Temple University Hospital and held this position previously at Hahnemann University Hospital and West Michigan Cancer Center. Dr. Miyamoto has been a reviewer of numerous journals including American Journal of Clinical Oncology and on the editorial board of Radiation Oncology Investigations. He is a member of several professional organizations at the local, regional, and national levels. He is involved in many committees at Temple University and Hahnemann University and their affiliated hospitals. Dr. Miyamoto has published over thirty peer-reviewed articles in various medical journals. In addition, he has written various other literatures including books, chapters, and abstracts in Radiation Oncology and holds two patents. He has given over a hundred presentations around the world regarding different aspects of radiation oncology and patients care. He is an executive board member for the Philadelphia County Medical Society, a founding member of the Association Ibero Latinoamericana de Terapia Radiante Oncologica, a founding board member of the Robert Zaloga Brain Tumor Foundation, and on the advisory board of the Prevent Cancer Foundation. Dr. Miyamoto is involved in cancer research and has research grants from U.S. Department of Defense and the Robert Zaloga Brain Tumor Foundation. He received his degree of B.S. in Biology from Muhlenberg College in Allentown, PA and M.D. degree from Universidad de Navarra in Spain. He completed his residency in radiation oncology from Hahnemann University Hospital in Philadelphia, PA. He currently holds a M.D. license in Pennsylvania since 1988. Dr. Miyamoto has won the Ôø_Physicians Recognition AwardÔø_ from the American Medical Association in 1994.

General External Beam Radiation
3-D Conformal Radiotherapy